Cell Microsystems provides the CellRaft AIR platform, an air‑based micro‑raft system that automates high‑throughput isolation, culture, and real‑time monitoring of single cells and 3‑D organoids. By eliminating high‑pressure sorting and manual dilution, the platform increases viable clone yields several‑fold and cuts clone generation time by about 50%, while offering imaging‑guided selection and rapid retrieval for downstream assays. It serves academic labs, biotech firms, and pharma R&D teams needing efficient single‑cell or organoid cloning for gene‑editing and therapeutic development.
Funding
$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
THFounders
Product
Problem
Researchers often rely on limiting dilution or flow sorting to isolate single cells or organoids, processes that are low‑throughput, time‑consuming, and can result in poor cell survival and low clone yields.
Solution
Cell Microsystems offers the CellRaft AIR platform, an air‑based micro‑raft system that automates the isolation, culture, and monitoring of individual cells and 3‑D organoids. By eliminating high‑pressure sorting and manual dilution steps, the system increases the number of viable clones obtained by several‑fold while cutting the time required for clone generation in half. Integrated imaging provides real‑time morphological data for each raft, enabling researchers to select and retrieve clones of interest with high confidence. The platform supports a range of cell types, including adherent lines, stem‑cell‑derived organoids, and CRISPR‑edited cells, streamlining workflows for cell engineering and functional assays.
Target Audience
Primary customers are academic research laboratories, biotech companies, and pharmaceutical R&D groups that require efficient single‑cell or organoid cloning for cell‑based assays, gene‑editing projects, and therapeutic development.
Features
- Air‑based micro‑raft isolation that gently captures single cells or organoids without high‑pressure stress
- Automated high‑throughput cloning that yields up to five times more clones compared to traditional methods
- Real‑time imaging and monitoring of each raft to assess morphology, growth, and viability before retrieval
- Compatible with adherent cell lines, stem‑cell‑derived organoids, and CRISPR‑edited populations
- Rapid retrieval of selected rafts for downstream culture, analysis, or assay development
- Scalable workflow that reduces clone generation time by approximately 50%